Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Participants in the cPKU group also showed elevated plasma vitamin B12 and folic acid levels compared to the other groups, and higher plasma vitamin D compared to subjects in the HPA group (Table S2). cPKU also showed significantly higher levels of arachidonic acid than the HPA group and higher levels of DHA compared to subjects in the PKU‐BH4 and controls.
Source: Characteristics of Study Participants by PKU Phenotypes and Control Group. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Observational study.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This cross‐sectional observational study was conducted from August 2022 to December 2023.
Source: Methods.
The study population comprised children aged 3 to 17 years, diagnosed with either mild hyperphenylalaninemia (HPA) or PKU through newborn screening and genetic confirmation.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status
Observational study · Journal of Inherited Metabolic Disease · 2026
Original publication title
Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status
© 2026 The Author(s). Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
What does the authors’ abstract report?
ABSTRACT
Individuals with phenylketonuria (PKU), caused by different variants of the phenylalanine hydroxylase gene, need to restrict their intake of phenylalanine. This study evaluated dietary patterns and physical activity levels in children with different PKU phenotypes compared to healthy controls. Eighty‐two children were recruited (22 classic PKU [cPKU], 21 BH4‐responsive PKU, 19 hyperphenylalaninemia, and 20 controls). Anthropometric data, dietary intake, biochemical markers, and physical activity were assessed. Classic PKU (cPKU) subjects exhibited higher carbohydrate and sugar intake than other PKU phenotypes and controls.
Notably, 42% of carbohydrate and 17% of sugar intake was from special low‐protein foods, and 20% of carbohydrate and 29% of sugar intake was from protein substitutes. Compared to controls, the cPKU group was less physically active and reported a higher frequency of sweet consumption. Ninety percent of PKU had good metabolic control and carbohydrate intake was significantly correlated with HOMA‐IR; however, after adjusting for age, only a trend remained (p = 0.08). Participants in the PKU group following a low natural protein diet consumed more carbohydrate and sugars than those on a normal‐protein diet.
Multivariate regression analysis showed that the low natural protein diet group was significantly associated with higher levels of vitamin B12, linoleic acid, α‐linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid, and with lower levels of total cholesterol and HDL‐C compared to the normal‐protein diet group. In conclusion, children with PKU, particularly those with classical PKU following low‐protein diets, showed higher carbohydrate intake and distinct micronutrient and lipid profiles compared with healthy controls.
Authors’ abstract
ABSTRACT
Individuals with phenylketonuria (PKU), caused by different variants of the phenylalanine hydroxylase gene, need to restrict their intake of phenylalanine. This study evaluated dietary patterns and physical activity levels in children with different PKU phenotypes compared to healthy controls. Eighty‐two children were recruited (22 classic PKU [cPKU], 21 BH4‐responsive PKU, 19 hyperphenylalaninemia, and 20 controls). Anthropometric data, dietary intake, biochemical markers, and physical activity were assessed. Classic PKU (cPKU) subjects exhibited higher carbohydrate and sugar intake than other PKU phenotypes and controls.
Notably, 42% of carbohydrate and 17% of sugar intake was from special low‐protein foods, and 20% of carbohydrate and 29% of sugar intake was from protein substitutes. Compared to controls, the cPKU group was less physically active and reported a higher frequency of sweet consumption. Ninety percent of PKU had good metabolic control and carbohydrate intake was significantly correlated with HOMA‐IR; however, after adjusting for age, only a trend remained (p = 0.08). Participants in the PKU group following a low natural protein diet consumed more carbohydrate and sugars than those on a normal‐protein diet.
Multivariate regression analysis showed that the low natural protein diet group was significantly associated with higher levels of vitamin B12, linoleic acid, α‐linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid, and with lower levels of total cholesterol and HDL‐C compared to the normal‐protein diet group. In conclusion, children with PKU, particularly those with classical PKU following low‐protein diets, showed higher carbohydrate intake and distinct micronutrient and lipid profiles compared with healthy controls.
Publication and source details
Original title: Comparative Analysis of Dietary Patterns in Children With Phenylketonuria Phenotypes and Controls: Implications for Nutritional Status
Dolores Garcia‐Arenas; Aida Ormazabal; Paula Isern; Blanca Barrau‐Martinez; Arnau Gonzalez‐Rodriguez; Alba Tor‐Roca; Rafael Llorach; Jaume Campistol‐Plana; Mireia Urpi‐Sarda; Consortium PKU.cat.
Journal of Inherited Metabolic Disease · 2026
* Correspondence:Mireia Urpi‐Sarda (murpi@ub.edu)
© 2026 The Author(s). Journal of Inherited Metabolic Disease published by John Wiley & Sons Ltd on behalf of SSIEM.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. Fundació La Marató de TV3, 202010.13039/100008666 202014 MICIU/AEI/10.13039/501100011033/FEDER PID2024‐156020OB‐I00 AGAUR‐Generalitat de Catalunya 2022 FI_B 010122024 FI‐1 00408 Ministry of Science, Innovation and Universities10.13039/100014440 FPU23/03478
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-10T23:17:23.363007+00:00
DOI: 10.1002/jimd.70196 · PMC13135907